Crosspoint Capital Strategies’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Crosspoint Capital Strategies’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-50	Closed	-$6K	–	1016
2015 Q4	$6K	Buy	+50	New	+$6K	﹤0.01%	797

Other funds holding SLXP

MAM

Mizuho Asset Management Tokyo, Japan $462M AUM 15.39% 1-Year Est. Return

Crosspoint Capital Strategies's SLXP Position: Q1 2016 in Review

Crosspoint Capital Strategies sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q1 2016, closing a stake of 50 shares — an estimated $6K sold.

Crosspoint Capital Strategies first reported a position in SLXP in Q4 2015 and held it in 1 quarter. The position peaked at $6K in Q4 2015. 1 fund tracked by Wall St. Rank holds SLXP as of Q1 2016.

Crosspoint Capital Strategies reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q1 2016 after selling out during the quarter.
Crosspoint Capital Strategies sold 50 SALIX PHARMACEUTICALS LTD DEL shares in Q1 2016, an estimated $6K.
Crosspoint Capital Strategies first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q4 2015 and held it in 1 quarter.
Crosspoint Capital Strategies's SALIX PHARMACEUTICALS LTD DEL position peaked at $6K in Q4 2015.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q1 2016.

Based on Crosspoint Capital Strategies's 13F filing for Q1 2016, filed 16 May 2016.